Reference
1. Zimmermann P, Curtis N. Coronavirus Infections in Children Including
COVID-19: An Overview of the Epidemiology, Clinical Features, Diagnosis,
Treatment and Prevention Options in Children. The Pediatric infectious
disease journal 2020;39(5):355.
2. Akcabelen YM, Yozgat AK, Parlakay AN, Yarali N. COVID‐19 in a child
with severe aplastic anemia. Pediatric blood & cancer
2020;67(8):e28443.
3. Dong Y, Mo X, Hu Y, Qi X, Jiang F, Jiang Z, et al. Epidemiological
characteristics of 2143 pediatric patients with 2019 coronavirus disease
in China. J Emerg Med 2020;58(4):712-713.
4. Ogimi C, Englund JA, Bradford MC, Qin X, Boeckh M, Waghmare A.
Characteristics and outcomes of coronavirus infection in children: the
role of viral factors and an immunocompromised state. Journal of the
Pediatric Infectious Diseases Society. 2019;8(1):21-8.
5. Fishman JA, Grossi PA. Novel Coronavirus‐19 (COVID‐19) in the
Immunocompromised Transplant Recipient:# Flatteningthecurve. Am J
Transplant 2020;20:1765-1767.
6. Okyay RA, Sahin AR, Aguinada RA, Tasdogan AM. Why are Children Less
Affected by COVID-19? Could there be an Overlooked Bacterial
Co-Infection? Pediatrics 2019;1:8.
7. D’Antiga L. Coronaviruses and immunosuppressed patients. The facts
during the third epidemic. Liver Transpl 2020;26:832-834.
8. Chen Z, Xiong H, Li J, Li H, Tao F, Yang Y, et al. COVID-19 with
post-chemotherapy agranulocytosis in childhood acute leukemia: a case
report. Zhonghua xueyexue zazhi 2020;41:E004.